Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lifevantage Debt to Equity Ratio 2010-2024 | LFVN

Current and historical debt to equity ratio values for Lifevantage (LFVN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Lifevantage debt/equity for the three months ending September 30, 2024 was 0.00.
  
Lifevantage Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.03B $0.03B 1.22
2024-06-30 $0.03B $0.03B 1.32
2024-03-31 $0.04B $0.03B 1.29
2023-12-31 $0.04B $0.03B 1.30
2023-09-30 $0.04B $0.03B 1.27
2023-06-30 $0.03B $0.04B 0.91
2023-03-31 $0.03B $0.03B 1.01
2022-12-31 $0.04B $0.03B 1.13
2022-09-30 $0.04B $0.03B 1.12
2022-06-30 $0.04B $0.03B 1.24
2022-03-31 $0.04B $0.03B 1.12
2021-12-31 $0.04B $0.04B 1.08
2021-09-30 $0.04B $0.04B 1.03
2021-06-30 $0.04B $0.04B 1.14
2021-03-31 $0.04B $0.04B 1.11
2020-12-31 $0.04B $0.04B 1.10
2020-09-30 $0.04B $0.03B 1.06
2020-06-30 $0.03B $0.03B 0.77
2020-03-31 $0.02B $0.03B 0.83
2019-12-31 $0.03B $0.03B 0.89
2019-09-30 $0.03B $0.03B 0.89
2019-06-30 $0.03B $0.03B 1.03
2019-03-31 $0.03B $0.03B 1.19
2018-12-31 $0.03B $0.02B 1.57
2018-09-30 $0.03B $0.02B 1.21
2018-06-30 $0.03B $0.02B 1.33
2018-03-31 $0.03B $0.02B 1.64
2017-12-31 $0.03B $0.02B 1.77
2017-09-30 $0.03B $0.02B 1.84
2017-06-30 $0.03B $0.02B 2.12
2017-03-31 $0.03B $0.01B 2.36
2016-12-31 $0.03B $0.02B 2.21
2016-09-30 $0.04B $0.01B 2.54
2016-06-30 $0.04B $0.01B 3.78
2016-03-31 $0.04B $0.01B 3.99
2015-12-31 $0.04B $0.01B 5.41
2015-09-30 $0.04B $0.01B 7.65
2015-06-30 $0.04B $0.00B 10.96
2015-03-31 $0.04B $0.00B 15.58
2014-12-31 $0.05B $0.01B 10.23
2014-09-30 $0.05B $0.01B 6.88
2014-06-30 $0.05B $0.00B 12.53
2014-03-31 $0.07B $0.00B 24.78
2013-12-31 $0.06B $-0.00B -116.68
2013-09-30 $0.02B $0.04B 0.55
2013-06-30 $0.02B $0.03B 0.64
2013-03-31 $0.02B $0.04B 0.56
2012-12-31 $0.02B $0.04B 0.57
2012-09-30 $0.02B $0.03B 0.47
2012-06-30 $0.02B $0.03B 0.57
2012-03-31 $0.01B $0.02B 0.48
2011-12-31 $0.02B $0.01B 1.64
2011-09-30 $0.03B $-0.02B -2.06
2011-06-30 $0.03B $-0.02B -1.60
2011-03-31 $0.02B $-0.01B -1.73
2010-12-31 $0.01B $-0.01B -2.63
2010-09-30 $0.02B $-0.01B -1.61
2010-06-30 $0.02B $-0.02B -1.39
2010-03-31 $0.02B $-0.01B -1.50
2009-12-31 $0.01B $-0.01B -1.88
2009-09-30 $0.01B $-0.01B -1.86
2009-06-30 $0.01B $-0.01B -1.84
2009-03-31 $0.01B $-0.00B -2.35
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.175B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Pro-Dex (PDEX) United States $0.140B 27.95